GlassScriptPhysician profile
Timothy D Groth
NPI 1093742272
$19,259.39
in general payments reported to CMS, 2019-2025
70 companies · $1,742 in 2025
The $1,742 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,894 · 2020: $2,231 · 2021: $3,183 · 2022: $3,570 · 2023: $2,932 · 2024: $2,707 · 2025: $1,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,381.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,705.00 | 2021-2025 | |
| Relievant Medsystems, INC. | $1,806.16 | 2019-2023 | Intracept |
| Abbott Laboratories | $1,040.05 | 2019-2025 | Proclaim |
| Scilex Pharmaceuticals INC. | $1,026.78 | 2019-2025 | Ztlido |
| Nevro Corp. | $973.57 | 2019-2024 | Senza |
| Boston Scientific Corporation | $938.90 | 2020-2025 | Intracept, General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $709.52 | 2019-2025 | Relistor |
| Medtronic, INC. | $704.24 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Arbor Pharmaceuticals, INC. | $665.42 | 2019-2022 | |
| Pfizer INC. | $606.83 | 2019-2025 | |
| Collegium Pharmaceutical, INC. | $568.11 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Allergan, INC. | $555.28 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $471.63 | 2019-2021 | |
| Amgen INC. | $357.21 | 2019-2022 | |
| Daiichi Sankyo INC. | $344.09 | 2019 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Groth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.